Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (6): 481-485.DOI: 10.3969/j.issn.1673-8640.2018.06.004
Previous Articles Next Articles
LI Linyun1, PENG Changhua1, MEI Bing1, DONG Li2
Received:
2017-03-29
Online:
2018-06-30
Published:
2018-07-06
CLC Number:
LI Linyun, PENG Changhua, MEI Bing, DONG Li. Correlation of ERAP-1 gene polymorphisms with ankylosing spondylitis in Chinese:a Meta analysis[J]. Laboratory Medicine, 2018, 33(6): 481-485.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.06.004
研究者 | 发表 年份 | 地区 | 病例组 (例) | 对照组 (名) | 研究位点 | |
---|---|---|---|---|---|---|
相关位点 | 不相关位点 | |||||
DAVIDSON等 | 2009 | 上海 | 527 | 945 | rs27980,rs27037,rs7711564 | rs27434 |
夏羽等 | 2011 | 济南 | 311 | 320 | rs27434,rs7711564 | |
LI等 | 2011 | 广州 | 471 | 456 | rs27434,rs27529 | rs27582 |
WU等 | 2012 | 济南 | 382 | 627 | rs27044 | |
WANG等 | 2012 | 台湾 | 797 | 1 150 | rs27037,rs27980,rs27044,rs30187 | |
ZHANG等 | 2014 | 北京 | 602 | 619 | rs27434 | rs27037,rs27980, rs27582 |
CHEN等 | 2015 | 天津 | 368 | 460 | rs27434,rs30187,rs10050860 | rs27044, rs2287987 |
曲哲等 | 2015 | 南京 | 195 | 203 | rs27434,rs27044,rs30187 | |
谢志雄等 | 2016 | 福建 | 149 | 150 | rs27980,rs30187,rs27044 | rs10050860,rs2287987, rs7711564,rs27529 |
合计 | 3 802 | 4 930 |
研究者 | 发表 年份 | 地区 | 病例组 (例) | 对照组 (名) | 研究位点 | |
---|---|---|---|---|---|---|
相关位点 | 不相关位点 | |||||
DAVIDSON等 | 2009 | 上海 | 527 | 945 | rs27980,rs27037,rs7711564 | rs27434 |
夏羽等 | 2011 | 济南 | 311 | 320 | rs27434,rs7711564 | |
LI等 | 2011 | 广州 | 471 | 456 | rs27434,rs27529 | rs27582 |
WU等 | 2012 | 济南 | 382 | 627 | rs27044 | |
WANG等 | 2012 | 台湾 | 797 | 1 150 | rs27037,rs27980,rs27044,rs30187 | |
ZHANG等 | 2014 | 北京 | 602 | 619 | rs27434 | rs27037,rs27980, rs27582 |
CHEN等 | 2015 | 天津 | 368 | 460 | rs27434,rs30187,rs10050860 | rs27044, rs2287987 |
曲哲等 | 2015 | 南京 | 195 | 203 | rs27434,rs27044,rs30187 | |
谢志雄等 | 2016 | 福建 | 149 | 150 | rs27980,rs30187,rs27044 | rs10050860,rs2287987, rs7711564,rs27529 |
合计 | 3 802 | 4 930 |
SNP位点 | 等位基因 | 数量 | 相关性分析 | 异质性分析 | |||||
---|---|---|---|---|---|---|---|---|---|
病例组(例) | 对照组(名) | OR(95%CI) | P值 | 效应模型 | P值 | ||||
rs30187 | C | 1 347 | 1 925 | 0.83(0.68~1.00) | 0.05 | R | 0.02 | ||
T | 1 671 | 1 991 | |||||||
rs27044 | G | 1 876 | 2 735 | 0.93(0.48~1.80) | 0.82 | R | <0.000 01 | ||
C | 1 904 | 2 443 | |||||||
rs10050860 | T | 60 | 198 | 0.63(0.07~5.82) | 0.69 | R | <0.000 01 | ||
C | 974 | 1 022 | |||||||
rs2287987 | C | 55 | 82 | 0.80(0.56~1.15) | 0.23 | F | 0.82 | ||
T | 979 | 1 138 | |||||||
rs27980 | C | 2 072 | 2 796 | 1.06(0.84~1.33) | 0.64 | R | 0.000 1 | ||
A | 1 998 | 2 724 | |||||||
rs711564 | C | 817 | 1 170 | 0.97(0.71~1.33) | 0.87 | R | 0.004 | ||
G | 779 | 1 150 | |||||||
rs27529 | G | 715 | 674 | 0.98(0.61~1.57) | 0.93 | R | 0.01 | ||
A | 525 | 538 | |||||||
rs27434 | A | 2 541 | 2 741 | 1.24(0.93~1.66) | 0.14 | R | <0.000 01 | ||
G | 2 309 | 2 993 | |||||||
rs27037 | T | 1 710 | 2 119 | 1.22(1.12~1.33) | <0.000 01 | F | 0.23 | ||
G | 2 052 | 3 061 | |||||||
rs27582 | A | 1 080 | 1 078 | 1.02(0.78~1.34) | 0.87 | R | 0.03 | ||
G | 1 058 | 1 070 |
SNP位点 | 等位基因 | 数量 | 相关性分析 | 异质性分析 | |||||
---|---|---|---|---|---|---|---|---|---|
病例组(例) | 对照组(名) | OR(95%CI) | P值 | 效应模型 | P值 | ||||
rs30187 | C | 1 347 | 1 925 | 0.83(0.68~1.00) | 0.05 | R | 0.02 | ||
T | 1 671 | 1 991 | |||||||
rs27044 | G | 1 876 | 2 735 | 0.93(0.48~1.80) | 0.82 | R | <0.000 01 | ||
C | 1 904 | 2 443 | |||||||
rs10050860 | T | 60 | 198 | 0.63(0.07~5.82) | 0.69 | R | <0.000 01 | ||
C | 974 | 1 022 | |||||||
rs2287987 | C | 55 | 82 | 0.80(0.56~1.15) | 0.23 | F | 0.82 | ||
T | 979 | 1 138 | |||||||
rs27980 | C | 2 072 | 2 796 | 1.06(0.84~1.33) | 0.64 | R | 0.000 1 | ||
A | 1 998 | 2 724 | |||||||
rs711564 | C | 817 | 1 170 | 0.97(0.71~1.33) | 0.87 | R | 0.004 | ||
G | 779 | 1 150 | |||||||
rs27529 | G | 715 | 674 | 0.98(0.61~1.57) | 0.93 | R | 0.01 | ||
A | 525 | 538 | |||||||
rs27434 | A | 2 541 | 2 741 | 1.24(0.93~1.66) | 0.14 | R | <0.000 01 | ||
G | 2 309 | 2 993 | |||||||
rs27037 | T | 1 710 | 2 119 | 1.22(1.12~1.33) | <0.000 01 | F | 0.23 | ||
G | 2 052 | 3 061 | |||||||
rs27582 | A | 1 080 | 1 078 | 1.02(0.78~1.34) | 0.87 | R | 0.03 | ||
G | 1 058 | 1 070 |
SNP位点 | 基因型 | 数量 | 相关性分析 | 异质性分析 | |||||
---|---|---|---|---|---|---|---|---|---|
病例组(例) | 对照组(例) | OR(95% CI) | P值 | 效应模型 | P值 | ||||
rs31087 | CC | 229 | 354 | 0.80(0.67~0.95) | 0.01 | F | 0.11 | ||
TC | 565 | 753 | |||||||
TT | 347 | 396 | |||||||
rs27044 | GG | 511 | 566 | 1.18(0.38~3.63) | 0.77 | R | <0.000 01 | ||
GC | 757 | 966 | |||||||
CC | 752 | 923 | |||||||
rs27980 | CC | 526 | 727 | 1.12(0.84~1.49) | 0.45 | R | 0.008 | ||
CA | 1 020 | 1 342 | |||||||
AA | 489 | 691 | |||||||
rs711564 | CC | 207 | 303 | 1.02(0.62~1.66) | 0.95 | R | 0.006 | ||
GC | 403 | 564 | |||||||
GG | 188 | 293 | |||||||
rs27434 | AA | 358 | 469 | 1.13(0.97~1.32) | 0.12 | F | 0.16 | ||
AG | 839 | 967 | |||||||
GG | 389 | 515 | |||||||
rs27037 | TT | 370 | 393 | 1.34(1.18~1.53) | <0.000 01 | F | 0.20 | ||
GT | 970 | 1 259 | |||||||
GG | 541 | 901 |
SNP位点 | 基因型 | 数量 | 相关性分析 | 异质性分析 | |||||
---|---|---|---|---|---|---|---|---|---|
病例组(例) | 对照组(例) | OR(95% CI) | P值 | 效应模型 | P值 | ||||
rs31087 | CC | 229 | 354 | 0.80(0.67~0.95) | 0.01 | F | 0.11 | ||
TC | 565 | 753 | |||||||
TT | 347 | 396 | |||||||
rs27044 | GG | 511 | 566 | 1.18(0.38~3.63) | 0.77 | R | <0.000 01 | ||
GC | 757 | 966 | |||||||
CC | 752 | 923 | |||||||
rs27980 | CC | 526 | 727 | 1.12(0.84~1.49) | 0.45 | R | 0.008 | ||
CA | 1 020 | 1 342 | |||||||
AA | 489 | 691 | |||||||
rs711564 | CC | 207 | 303 | 1.02(0.62~1.66) | 0.95 | R | 0.006 | ||
GC | 403 | 564 | |||||||
GG | 188 | 293 | |||||||
rs27434 | AA | 358 | 469 | 1.13(0.97~1.32) | 0.12 | F | 0.16 | ||
AG | 839 | 967 | |||||||
GG | 389 | 515 | |||||||
rs27037 | TT | 370 | 393 | 1.34(1.18~1.53) | <0.000 01 | F | 0.20 | ||
GT | 970 | 1 259 | |||||||
GG | 541 | 901 |
[1] | NG S C,LIAO Z,YU D T,et al.Epidemiology of spondyloarthritis in the People's Republic of China:review of the literature and commentary[J]. Semin Arthritis Rheum,2007,37(1):39-47. |
[2] | FIERABRACCI A,MILILLO A,LOCATELLI F,et al.The putative role of endoplasmic reticulum aminopeptidases in autoimmunity:insights from genomic-wide association studies[J]. Autoimmun Rev,2012,12(2):281-288. |
[3] | Australo-Anglo-American Spondyloarthritis Consortium(TASC),REVEILLE J D,SIMS A M,et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci[J]. Nat Genet,2010,42(2):123-127. |
[4] | 王玲,奚永志,孙玉英. ERAP1基因多态性和HLA-B27相互作用与强直性脊柱炎关联的研究进展[J]. 生物技术通讯,2016,27(1):124-127. |
[5] | CAI G,XIN L,WANG L,et al.Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility:an updated meta-analysis[J]. Mod Rheumatol,2015,25(3):453-461. |
[6] | CINAR M,AKAR H,YILMAZ S,et al.A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population[J]. Rheumatol Int,2013,33(11):2851-2858. |
[7] | CHERCIU M,POPA L O,BOJINCA M,et al.Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis[J]. Tissue Antigens,2013,82(3):192-196. |
[8] | DAVIDSON S I,WU X,LIU Y,et al.Association of ERAP1,but not IL23R,with ankylosing spondylitis in a Han Chinese population[J]. Arthritis Rheum,2009,60(11):3263-3268. |
[9] | 夏羽,王来城,孙慧,等. ERAP1基因与山东汉族人群强直性脊柱炎的相关性[J]. 山东大学学报(医学版),2011,49(10):127-130. |
[10] | 杨克虎. 系统评价指导手册[M]. 北京:人民卫生出版社,2010:58. |
[11] | LI C,LIN Z,XIE Y,et al.ERAP1 is associated with ankylosing spondylitis in Han Chinese[J]. J Rheumatol,2011,38(2):317-321. |
[12] | WU W,DING Y,CHEN Y,et al.Susceptibility to ankylosing spondylitis:evidence for the role of ERAP1,TGFb1 and TLR9 gene polymorphisms[J]. Rheumatol Int,2012,32(8):2517-2521. |
[13] | WANG C M,HO H H,CHANG S W,et al.ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis[J]. Arthritis Res Ther,2012,14(3):R125. |
[14] | ZHANG Z,DAI D,YU K,et al.Association of HLA-B27 and ERAP1 with ankylosing spondylitis susceptibility in Beijing Han Chinese[J]. Tissue Antigens,2014,83(5):324-329. |
[15] | CHEN C,ZHANG X.ERAP1 variants are associated with ankylosing spondylitis in East Asian population:a new Chinese case-control study and meta-analysis of published series[J]. Int J Immunogenet,2015,42(3):168-173. |
[16] | 曲哲,钱邦平,邱勇,等. ERAP1基因单核苷酸多态性与中国汉族人群强直性脊柱炎的易感性关联分析[J]. 中国脊柱脊髓杂,2015,25(9):832-836. |
[17] | 谢志雄,吴丽萍,房光萃,等. 内质网氨基肽酶-1基因(ERAP1)多态性与闽南地区汉族人群强直性脊柱炎关联性研究[J]. 现代免疫学,2016,36(3):224-229. |
[18] | HAROON N,TSUI F W, UCHANSKA-ZIEGLER B,et al.Endoplasmic reticulum aminopeptidase 1(ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis[J]. Ann Rheum Dis,2012,71(4):589-595. |
[19] | EVANS D M,SPENCER C C,POINTON J J,et al.Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility[J]. Nat Genet,2011,43(8):761-767. |
[1] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
[2] | MA Dongmei, JIANG Dongkui, XIANG Xiaobo, LI Shiliang. Antibacterial activity of 4 Chinese herbal medicines alone and combined with western medicines for extensively drug resistant Acinetobacter baumannii [J]. Laboratory Medicine, 2023, 38(5): 441-445. |
[3] | ZHOU Furong, LI Yanzhu, LIU Yonggan. Application of lncRNA SNP in colorectal cancer susceptibility prediction and prognosis assessment [J]. Laboratory Medicine, 2023, 38(12): 1206-1210. |
[4] | YAN An, GUAN Xuhuizi, YU Tian, MIAO Gang, ZHAO Yanyang. Identification of a new susceptibility gene variant EPB41L4A rs1455421289 in Chinese PTC patients by WES [J]. Laboratory Medicine, 2023, 38(11): 1009-1014. |
[5] | WAN Changchun, YANG Hui, ZHUANG Xuewei. Application of polymerase chain reaction melting curve method in determining hypertensive drug-related gene mutations [J]. Laboratory Medicine, 2022, 37(7): 646-651. |
[6] | HE Yaya, CHEN Shanshan, LI Yongsheng, LIU Juan. Expressions of sLAIR-1 and LAIR-1 mRNA in AS patients and their relationship with disease activity [J]. Laboratory Medicine, 2022, 37(10): 915-920. |
[7] | XIN Ran, GAO Xiang, AN Haiying, XIN Guangqin, DAI Weili, GONG Jingshu. Correlation analysis of drug resistance and antibiotic usage in a Grade 3 traditional Chinese medicine hospital [J]. Laboratory Medicine, 2021, 36(8): 809-813. |
[8] | ZHANG Guanyi, YAO Dongting, WANG Jian, HU Xiaobo. Research progress on Chinese and western medicine treatment for Candida glabrata infection [J]. Laboratory Medicine, 2021, 36(7): 761-765. |
[9] | TIAN Yueru, WANG Jingjing, AI Fuqi, MA Yimin, WANG Bei, JIANG Xiaofei. Performance evaluation of Vitek 2 Compact AST-N334,AST-N335,AST-P639 Chinese antimicrobial susceptibility test cards [J]. Laboratory Medicine, 2021, 36(4): 417-423. |
[10] | LI Shichao, SHEN Liang, WANG Chunhua, TONG Yanfei, ZHANG Ji. Diagnostic value of SARS-CoV-2 antibody to COVID-19:a meta-analysis [J]. Laboratory Medicine, 2021, 36(1): 39-43. |
[11] | ZHANG Minjie, GAO Yufang, YANG Feifei, XU Xiaoli. Meta analysis on the positive detection rate of anti-Epstein-Barr virus antibodies in Chinese population with infectious mononucleosis [J]. Laboratory Medicine, 2020, 35(3): 214-223. |
[12] | LI Rui, SHI Panlai, WANG Ailing, WANG Jianhong, XIAO Yanhua, KONG Xiangdong. Application of single nucleotide polymorphism array for fetuses with thickened nuchal translucency [J]. Laboratory Medicine, 2020, 35(2): 142-147. |
[13] | WU Beiying, GU Yanying, FAN Zhenjia, CAI Gang. Establishment of HLA-B27 cut-off value by flow cytometry and related grey zone sample genotype determination [J]. Laboratory Medicine, 2020, 35(1): 15-19. |
[14] | WANG Jing, ZHENG Qun, JIN Xiaxia, LU Guoguang, SHEN Bo. Role of RDW combined determination with NLR in ankylosing spondylitis [J]. Laboratory Medicine, 2019, 34(8): 704-709. |
[15] | TONG Minghong, DING Hui, JIANG Yinting, SUN Hanxiao, XUAN Binbin, SHENG Huiming. Role of the determination of statin metabolism-related gene in the treatment of cardiovascular and cerebrovascular diseases [J]. Laboratory Medicine, 2019, 34(6): 491-497. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||